Literature DB >> 4166917

Renal tubular acidosis. Three cases with immunoglobulin abnormalities in the patients and their kindreds.

I D Wilson, R C Williams, L Tobian.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4166917     DOI: 10.1016/0002-9343(67)90192-1

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  9 in total

1.  Human serum antibodies specific for secretory IgA.

Authors:  I D Wilson
Journal:  Immunology       Date:  1972-06       Impact factor: 7.397

2.  Fibrosing alveolitis associated with renal tubular acidosis.

Authors:  A M Mason; M B McIllmurray; P L Golding; D T Hughes
Journal:  Br Med J       Date:  1970-12-05

3.  Renal tubular acidosis: an immunopathological study on four patients.

Authors:  A Pasternack; E Linder
Journal:  Clin Exp Immunol       Date:  1970-07       Impact factor: 4.330

4.  Liver disease--a prominent cause of serum IgE elevation.

Authors:  E Van Epps; G Husby; R C Williams; R G Strickland
Journal:  Clin Exp Immunol       Date:  1976-03       Impact factor: 4.330

5.  Peripheral blood and intestinal lymphocyte sub-populations in Crohn's disease.

Authors:  R G Strickland; G Husby; W C Black; R C Williams
Journal:  Gut       Date:  1975-11       Impact factor: 23.059

6.  Hyperglobulinaemic renal tubular acidosis: a report of nine cases.

Authors:  A M Mason; P L Golding
Journal:  Br Med J       Date:  1970-07-18

7.  Renal tubular acidosis: its types and role in renal calculosis.

Authors:  Z Szendröi; K Simon; L Kiss
Journal:  Int Urol Nephrol       Date:  1982       Impact factor: 2.370

8.  Multiple immunological abnormalities in a family.

Authors:  A M Mason; P L Golding
Journal:  J Clin Pathol       Date:  1971-11       Impact factor: 3.411

9.  Suppression of leukocyte chemotaxis by human IgA myeloma components.

Authors:  D E Van Epps; R C Williams
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.